MB MBX Biosciences, Inc. Stock: price and directors' dealings · United States · SEC (Form 4)Follow the MBX Biosciences, Inc. share price and the full insider trade history of the company, a listed issuer based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €3.3bn. The latest transaction was reported on 17 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Hawryluk P. Kent. The full history is free.
Analyst consensus: bullish or bearish? Analysts rate MBX Biosciences, Inc. Strong Buy (bullish), based on 10 analysts. Average price target: US$88.40.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 17 August 2026
All Executives39 Thresholds0 Prospectus0 Other0
Declarations 39 total
● Former Officer · Executives · 17 Aug 2026
3,745 shares @ US$68.2876 0.0077% mcap 9.3% of flow Common SEC144:0001959173-26-006112
▼ Chief Medical Officer · Executives · 4 Aug 2026
370 shares @ US$65.77 0.0008% mcap 50.0% of flow Common Stock SEC:0001193125-26-335373:0
● Officer, Director · Executives · 4 Aug 2026
936 shares @ US$65.7729 0.0020% mcap 2.5% of flow Common SEC144:0001959173-26-005629
● Officer · Executives · 4 Aug 2026
370 shares @ US$65.7729 0.0008% mcap 100.0% of flow Common SEC144:0001959173-26-005628
◆ Chief Financial Officer · Executives · 3 Aug 2026
28,000 shares 0Common Stock SEC:0001193125-26-331642:0
◆ President and CEO · Executives · 3 Aug 2026
71,000 shares 0Common Stock SEC:0001193125-26-331639:0
● Former Officer · Executives · 10 Jun 2026
9,167 shares @ US$30.5454 0.0095% mcap 46.6% of flow Common SEC144:0001959173-26-004511
● Former Officer · Executives · 9 Jun 2026
10,833 shares @ US$29.6569 0.011% mcap 53.4% of flow Common SEC144:0001959173-26-004487
▲ President & CEO · Executives · 13 Mar 2026
18,500 shares @ US$28.4142 46.9% of flow Common Stock SEC:0001193125-26-107268:0
Canonical exit: 11 Jun 2026 (T+90) ◇ President & CEO · Executives · 26 Feb 2026
28,768 shares @ US$16.00 18.5% of flow Common Stock SEC:0001193125-26-082562:0
◆ Chief Medical Officer · Executives · 2 Feb 2026
15,000 shares 0Common Stock SEC:0001193125-26-035587:0
◆ Chief Financial Officer · Executives · 2 Feb 2026
15,000 shares 0Common Stock SEC:0001193125-26-035584:0
◆ President & CEO · Executives · 2 Feb 2026
35,250 shares 0Common Stock SEC:0001193125-26-035582:0
◇ President & CEO · Executives · 24 Oct 2025
182,859 shares @ US$3.25 29.7% of flow Common Stock SEC:0001193125-25-252404:0
▲ President & CEO · Executives · 20 Oct 2025
20,000 shares @ US$13.6395 13.6% of flow Common Stock SEC:0001193125-25-245411:0
Canonical exit: 18 Jan 2026 (T+90) ▲ Director · Executives · 17 Oct 2025
20,000 shares @ US$13.2492 100.0% of flow Common Stock SEC:0001193125-25-243653:0
Canonical exit: 15 Jan 2026 (T+90) ▲ Director · Executives · 26 Sept 2025
666,666 shares @ US$18.00 100.0% of flow Common Stock SEC:0001231919-25-000267:0
Canonical exit: 25 Dec 2025 (T+90) ▲ Director · Executives · 8 Apr 2025
7,693 shares @ US$5.89 100.0% of flow Common Stock SEC:0000950170-25-052685:0
Canonical exit: 7 Jul 2025 (T+90) ▲ Director · Executives · 14 Feb 2025
17,962 shares @ US$9.90 100.0% of flow Common Stock SEC:0000947871-25-000200:0
Canonical exit: 15 May 2025 (T+90) ▲ Director · Executives · 14 Feb 2025
17,962 shares @ US$9.90 100.0% of flow Common Stock SEC:0000947871-25-000199:0
Canonical exit: 15 May 2025 (T+90) ▲ President & CEO · Executives · 4 Feb 2025
50,000 shares @ US$10.69 100.0% of flow Common Stock SEC:0000950170-25-014494:0
Canonical exit: 5 May 2025 (T+90) ● Director · Executives · 16 Sept 2024
2,658,428 shares Common Stock SEC:0000950170-24-107524:0
● Director · Executives · 16 Sept 2024
1,386,335 shares Common Stock SEC:0000950170-24-107525:0
● Director · Executives · 16 Sept 2024
1,023,103 shares Common Stock SEC:0000950170-24-107558:0
1,023,103 shares Common Stock SEC:0000950170-24-107542:0
25 of 39 declarations
Load more (14 remaining) 关于 MBX Biosciences, Inc. MBX Biosciences, Inc. 是一家生物技术公司，专注于开发代谢疾病的创新疗法。该公司在纳斯达克上市，股票代码为 MBX。